Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Pharma Mar SA ( (ES:PHM) ).
Pharma Mar SA announced the payment of a dividend from its share premium reserve, set to be distributed on June 27, 2025, at a net amount of 0.80 euros per share. This move reflects the company’s commitment to providing value to its shareholders and could enhance its market position by demonstrating financial stability and shareholder-friendly policies.
The most recent analyst rating on (ES:PHM) stock is a Buy with a EUR108.00 price target. To see the full list of analyst forecasts on Pharma Mar SA stock, see the ES:PHM Stock Forecast page.
More about Pharma Mar SA
Pharma Mar SA is a company operating in the pharmaceutical industry, primarily focused on the development and commercialization of marine-based drugs for cancer treatment. The company is known for its innovative approach to oncology and has a significant presence in the global pharmaceutical market.
Average Trading Volume: 65,804
Technical Sentiment Signal: Buy
Current Market Cap: €1.47B
For a thorough assessment of PHM stock, go to TipRanks’ Stock Analysis page.